DK1766412T3 - Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner - Google Patents

Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner

Info

Publication number
DK1766412T3
DK1766412T3 DK05751819T DK05751819T DK1766412T3 DK 1766412 T3 DK1766412 T3 DK 1766412T3 DK 05751819 T DK05751819 T DK 05751819T DK 05751819 T DK05751819 T DK 05751819T DK 1766412 T3 DK1766412 T3 DK 1766412T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
serum glycoproteins
quantifying serum
quantifying
Prior art date
Application number
DK05751819T
Other languages
English (en)
Inventor
Rudolph H Aebersold
Hui Zhang
Original Assignee
Inst Systems Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Systems Biology filed Critical Inst Systems Biology
Application granted granted Critical
Publication of DK1766412T3 publication Critical patent/DK1766412T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
DK05751819T 2004-05-21 2005-05-20 Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner DK1766412T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57359304P 2004-05-21 2004-05-21
PCT/US2005/017842 WO2005114221A2 (en) 2004-05-21 2005-05-20 Compositions and methods for quantification of serum glycoproteins

Publications (1)

Publication Number Publication Date
DK1766412T3 true DK1766412T3 (da) 2009-05-25

Family

ID=35429005

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05751819T DK1766412T3 (da) 2004-05-21 2005-05-20 Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner

Country Status (6)

Country Link
US (2) US20060141528A1 (da)
EP (4) EP2302393A1 (da)
AT (1) ATE427499T1 (da)
DE (1) DE602005013670D1 (da)
DK (1) DK1766412T3 (da)
WO (1) WO2005114221A2 (da)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124265D1 (de) * 2000-05-05 2006-12-14 Purdue Research Foundation Durch affinität ausgewählte unterschriftspeptide zur identifizierung und quantifizierung von proteinen
WO2003027682A2 (en) * 2001-09-27 2003-04-03 Purdue Research Foundation Controlling isotope effects during fractionation of analytes
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
US7384754B2 (en) * 2003-10-31 2008-06-10 Agilent Technologies, Inc. Enrichment and tagging of glycosylated proteins
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
WO2007047796A2 (en) * 2005-10-17 2007-04-26 Institute For Systems Biology Tissue-and serum-derived glycoproteins and methods of their use
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
WO2008021290A2 (en) * 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
US7879799B2 (en) * 2006-08-10 2011-02-01 Institute For Systems Biology Methods for characterizing glycoproteins and generating antibodies for same
AU2007342674B2 (en) * 2007-01-10 2013-09-19 Purdue Research Foundation Polypeptide inhibitors of HSP27 kinase and uses therefor
WO2008134526A2 (en) * 2007-04-27 2008-11-06 University Of Florida Research Foundation Inc. Glycoprotein profiling of bladder cancer
WO2008151238A1 (en) * 2007-06-04 2008-12-11 The Johns Hopkins University Biomarkers for prostate cancer
US20100168382A1 (en) * 2007-06-12 2010-07-01 Vladimir Berezin Neuroplastin derived peptides
EP2171080A4 (en) 2007-06-12 2010-10-27 Glaxosmithkline Llc METHODS OF PROTEIN DETECTION IN PLASMA
CA2692970A1 (en) * 2007-07-03 2009-01-08 Northeastern University Biomarkers for diabetes, obesity, and/or hypertension
WO2009014450A1 (en) * 2007-07-24 2009-01-29 Sanare As Novel peptides with anti-tumor activity
WO2009021137A2 (en) 2007-08-07 2009-02-12 Purdue Research Foundation Kinase inhibitors and uses thereof
AU2009208607B2 (en) * 2008-01-31 2013-08-01 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
US9327008B2 (en) 2008-12-10 2016-05-03 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
EP2427844A4 (en) 2009-05-08 2016-11-02 Thermo Finnigan Llc PROCESSES AND SYSTEMS FOR VOTING PRODUCTS AND PRE-REFERENCES
CN102695716B (zh) * 2009-07-14 2016-03-02 独立行政法人产业技术综合研究所 肝病病情指标糖链标记物
US9890195B2 (en) 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
JP5756169B2 (ja) * 2010-05-14 2015-07-29 ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド タンパク質信頼値を計算するためのシステムおよび方法
TW201708251A (zh) * 2010-10-27 2017-03-01 巴克斯歐塔公司 用於免疫耐受誘導及免疫診斷之ｆｖｉｉｉ胜肽
US9403889B2 (en) 2010-11-29 2016-08-02 Integrated Diagnostics, Inc. Diagnostic lung cancer panel and methods for its use
US8772043B2 (en) 2010-12-23 2014-07-08 Pioneer Hi Bred International Inc Universal peptide tags for transgene polypeptide analysis by mass spectrometry
WO2012156665A2 (en) * 2011-05-13 2012-11-22 King's College London Methods and compositions relating to platelet sensitivity
US8455624B2 (en) 2011-06-03 2013-06-04 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
US9506167B2 (en) 2011-07-29 2016-11-29 Ginkgo Bioworks, Inc. Methods and systems for cell state quantification
CA2848162C (en) 2011-09-12 2023-03-14 Creatics Llc Non-invasive methods of detecting target molecules
CN103134874B (zh) * 2011-12-01 2015-05-20 成都康弘生物科技有限公司 一种测定蛋白中糖基的方法
CA2860298A1 (en) 2011-12-21 2013-06-27 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US9304137B2 (en) 2011-12-21 2016-04-05 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US11913957B2 (en) 2011-12-21 2024-02-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
CA2859777C (en) 2012-01-09 2020-06-30 Serpin Pharma, Llc Serine protease inhibitor (serpin) peptides and methods thereof
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
US20150299283A1 (en) * 2012-11-06 2015-10-22 University Of Miyazaki Novel peptide and application thereof
WO2014100717A2 (en) 2012-12-21 2014-06-26 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
JP6646571B2 (ja) 2013-03-13 2020-02-14 クリエイティクス エルエルシー 膵臓がんを検出するための方法および組成物
GB201310150D0 (en) * 2013-06-07 2013-07-24 Electrophoretics Ltd Methods and compositions relating to alzheimer's disease
WO2015013654A1 (en) 2013-07-26 2015-01-29 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
US9594085B2 (en) 2014-02-03 2017-03-14 Integrated Diagnostics, Inc. Integrated quantification method for protein measurements in clinical proteomics
GB201411037D0 (en) * 2014-06-20 2014-08-06 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
US10000533B2 (en) 2014-06-20 2018-06-19 Immatics Biotechnologies Gmbh Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL)
WO2016038608A1 (en) * 2014-09-08 2016-03-17 Carmel Haifa University Economic Corporation Ltd. Peptides derived from angiotensin receptor and use thereof
US10035823B2 (en) * 2014-09-29 2018-07-31 The Regents Of The University Of California Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
MY193703A (en) 2015-03-27 2022-10-26 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various tumors
CN113425837A (zh) 2015-08-28 2021-09-24 赛品制药有限责任公司 用于疾病治疗的方法
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520559D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
CN110114680A (zh) 2016-05-05 2019-08-09 佰欧迪塞克斯公司 用于诊断肺癌的组合物、方法和试剂盒
US9960027B2 (en) 2016-05-25 2018-05-01 Thermo Finnigan Llc Analyzing a complex sample by MS/MS using isotopically-labeled standards
JP2020532732A (ja) * 2017-09-01 2020-11-12 ヴェン バイオサイエンシズ コーポレーション 診断および治療モニタリングのためのバイオマーカーとしての糖ペプチドの同定および使用
ES2710321A1 (es) * 2017-10-20 2019-04-24 Consejo Superior Investigacion Adn polimerasas independientes de cebador y su uso para la sintesis de adn
WO2020223646A1 (en) 2019-05-02 2020-11-05 Creatics Llc Methods for cancer detection by evaluation of alpha-1-antitrypsin (aat) and chymotrypsin-like elastase in gastrointestinal lavage fluid samples
CN110563844A (zh) * 2019-09-04 2019-12-13 华中农业大学 一种抗犬白介素31受体的多克隆抗体及其应用
US20220348620A1 (en) * 2019-09-09 2022-11-03 The Wistar Institute Of Anatomy And Biology Engineered Peptide and Peptide Mimetic Compositions and Methods
EP4329793A2 (en) * 2021-04-29 2024-03-06 Seer, Inc. Peptide decorated nanoparticles for enrichment of specific protein subsets
CN113480629B (zh) * 2021-06-16 2022-08-19 复旦大学 区分肝癌和正常人的末端唾液酸化异构糖肽标志物及其筛查方法
US11542340B1 (en) 2021-10-29 2023-01-03 Biodesix, Inc. Antibodies targeting pulmonary nodule specific biomarkers and uses thereof
NL2030990B1 (en) * 2022-02-17 2023-09-01 Academisch Ziekenhuis Leiden T cell receptors directed against jchain and uses thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2226032B (en) * 1988-12-16 1993-08-18 Urs Heimgartner Detection of glycoproteins
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5264563A (en) 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
GB9112504D0 (en) * 1991-06-11 1991-07-31 Merck Sharp & Dohme Cell line
US5986076A (en) 1994-05-11 1999-11-16 Trustees Of Boston University Photocleavable agents and conjugates for the detection and isolation of biomolecules
DE69531545T2 (de) 1994-06-23 2004-06-24 Affymax Technologies N.V., Willemstad Photolabile verbindungen und verfahren für deren verwendung
CA2257357C (en) * 1996-06-07 2010-04-13 Neorx Corporation Humanized antibodies with modified glycosylation
WO1998025574A2 (en) * 1996-12-10 1998-06-18 Sloan-Kettering Institute For Cancer Research Stimulation of an immune response to differentiation antigen stimulated by altered antigen
US6046013A (en) * 1997-08-01 2000-04-04 Gti Process for identifying specific antibodies associated with HLA
JP3345401B2 (ja) 1998-08-25 2002-11-18 ユニバーシティ オブ ワシントン 複合した混合物中のタンパク質またはタンパク質機能の迅速定量分析
US6407210B1 (en) * 1998-11-09 2002-06-18 University Of Utah Research Foundation Nematode neuromuscular junction GABA receptors and methods related thereto
AU5047800A (en) * 1999-05-28 2000-12-18 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
ATE475092T1 (de) 2000-12-26 2010-08-15 Inst Systems Biology Schnelle und quantitative proteomanalyse und entsprechende verfahren
MXPA03009957A (es) * 2001-04-30 2005-07-25 Vertex Pharma Inhibidores de la gsk-3 y estructuras cristalinas de la proteina gsk-3¦ y complejos de proteina.
WO2003027682A2 (en) * 2001-09-27 2003-04-03 Purdue Research Foundation Controlling isotope effects during fractionation of analytes
EP1514107B1 (en) * 2002-06-03 2013-05-15 The Institute for Systems Biology Methods for quantitative proteome analysis of glycoproteins
US7794947B2 (en) * 2003-07-10 2010-09-14 Institute For Systems Biology Affinity capture of peptides by microarray and related methods
US7593336B2 (en) * 2003-10-31 2009-09-22 Brocade Communications Systems, Inc. Logical ports in trunking
US7348416B2 (en) * 2003-11-21 2008-03-25 Applera Corporation Selective capture and enrichment of proteins expressed on the cell surface

Also Published As

Publication number Publication date
EP1766412A2 (en) 2007-03-28
EP2093569A2 (en) 2009-08-26
WO2005114221A8 (en) 2006-05-04
DE602005013670D1 (de) 2009-05-14
ATE427499T1 (de) 2009-04-15
US20060141528A1 (en) 2006-06-29
EP2093569A3 (en) 2009-11-11
US20100279382A1 (en) 2010-11-04
EP2302393A8 (en) 2011-08-03
EP2302393A1 (en) 2011-03-30
WO2005114221A2 (en) 2005-12-01
WO2005114221A3 (en) 2006-12-21
EP2302394A1 (en) 2011-03-30
EP1766412B1 (en) 2009-04-01

Similar Documents

Publication Publication Date Title
DK1766412T3 (da) Sammensætninger og fremgangsmåder til kvantificering af serumglycoproteiner
HUP0200400A2 (hu) Fehérjék izolálása és elemzése
DE60214060D1 (de) Vorrichtung zur Bereitstellung von Wegbeschreibung
WO2005012574A3 (en) Biological bar-code
DK1510492T3 (da) Fremgangsmåde til afprövning af et elevatoranlæg og elevatoranlæg
WO2007007192A8 (en) Use of ionic matrices for maldi mass spectrometry analysis of tissue sections
DK1663298T3 (da) Anvendelse af prolinspecifikke endoproteaser til hydrolyse af peptider og proteiner
DK1740197T3 (da) Prolyl-endopeptidease (PEP) og glutamin-endoprotease til behandlingen af cøliaki
DK2270189T3 (da) Glyphosattolerante lucernebegivenheder og fremgangsmåder til detektering deraf
IS6316A (is) Aðferð til erfðafræðilegra greininga
DK1680443T3 (da) Stabiliserede alfa-helix-peptider og anvendelser heraf
CY1106115T1 (el) Προσδιορισμος κινασης αναπλαστικου λεμφωματος, αντιδραστηρια και συνθεσεις αυτης
DK2327792T3 (da) Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme
EP1700120A4 (en) MARKER FOR OPTICAL NEUROMYELITIS
DK1368689T3 (da) Fremgangsmåde til estimering af den bedste indledende fokusposition
FI20012271A0 (fi) Menetelmä vastinpisteiden määrittämiseksi
DK1444358T3 (da) Fremgangsmåde til karakterisering og/eller identificering af aktive mekanismer af antimikrobielle teststoffer
ATE363070T1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
DE60213940D1 (de) Proben-Einführungssystem
MXPA04004018A (es) Metodos de separacion por exclusion para toxicidad de compuestos de prueba.
DE60219633D1 (de) LÄNGLICHER KANISTER FÜr EINEN AUTOMATISIERTEN MIKROBIOLOGISCHEN ANALYSATOR
DE60232728D1 (de) Einrichtung zur erzeugung von gegenseitigen photometrischen effekten
WO2007095378A3 (en) Mass tagging for quantitative analysis of biomolecules using 13c labeled phenylisocyanate
EP1468265A4 (en) SYSTEMS AND METHOD FOR PROTEIN PHOSPHORYLATION ANALYSIS
AU2003209735A1 (en) Filament-recruiting fluorescent proteins for the analysis and identification of protein-protein-interactions